Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Stockholders' Deficit

v3.19.3
Note 6 - Stockholders' Deficit
3 Months Ended
Sep. 30, 2019
Stockholders' deficit:  
Stockholders' Deficit

Warrant Activity

 

Warrant detail for the three months ended September 30, 2019 is reflected below:

 

   

Number of

Warrants

   

Weighted

Average

Exercise

Price Per

Warrant

   

Remaining

Contract

Term (# years)

 
Warrants outstanding and exercisable at June 30, 2019     8,333     $ 20.00       0.25  
Warrants issued     -     $ -       -  
Warrants exchanged       -   $ -         -
Warrants forfeited     (8,333)     $ 20.00       -  
Warrants outstanding and exercisable at September 30, 2019     -     $ -       -  

  

Warrant detail for the three months ended September 30, 2018 is reflected below:

 

   

Number of

Warrants

   

Weighted

Average

Exercise

Price Per

Warrant

   

Remaining

Contract

Term (# years)

 
Warrants outstanding and exercisable at June 30, 2018     174,079     $ 20.30       0.74  
Warrants issued     -     $ -       -  
Warrants exchanged     (4,000)     $ 20.00       -  
Warrants forfeited     -     $ -       -  
Warrants outstanding and exercisable at September 30, 2018     170,079     $ 20.30       0.47  

 

Stock-based Compensation 

 

On November 26, 2014, the board of directors approved the 2014 Equity Incentive Plan (the “2014 Plan”), which was approved by the Company’s stockholders on February 17, 2015. The 2014 Plan offers selected employees, directors, and consultants the opportunity to acquire our common stock, and serves to encourage such persons to remain employed by us and to attract new employees. The 2014 Plan allows for the award of stock and options, up to 1,000,000 shares of our common stock.  

 

Activity in stock options during the three months ended September 30, 2019 and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2019     580,171     $ 11.05       8.59  
Granted     -     $ -       -  
Exercised     (4,437)     $ 4.69       -  
Forfeited and cancelled     (4,313)     $ 10.34       -  
Outstanding at September 30, 2019          571,421     $ 11.10       8.31  
Exercisable at September 30, 2019     339,420     $ 10.32       7.84  

 

Activity in stock options during the three months ended September 30, 2018 and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

 

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2018     354,447     $ 8.30       8.87  
Granted     33,526     $ -       -  
Exercised     -       -       -  
Forfeited and cancelled     (10,312 )   $ -       -  
Outstanding at September 30, 2018     376,661     $ 9.40       8.33  
Exercisable at September 30, 2018     160,967     $ 7.70       7.99  

 

Stock-based compensation expense recognized in the condensed consolidated statements of operations for the three months ended September 30, 2019 and 2018, includes compensation expense for stock-based options and awards granted based on the grant date fair value. For options and awards granted, expenses are amortized under the straight-line method over the expected vesting period. Stock-based compensation expense recognized in the condensed consolidated statements of operations has been reduced for estimated forfeitures of options that are subject to vesting. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

At September 30, 2019, the aggregate intrinsic value of exercisable options was $659,000 .

 

The Company allocated stock-based compensation expense included in the condensed consolidated statements of operations for employee option grants and non-employee option grants as follows:

 

Three months ended September 30,   2019     2018  
Research and development   $ 54,000     $ 15,000  
Selling and administrative     397,000       149,000  
Total stock-based compensation expense   $ 451,000     $ 164,000  

 

The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:

 

Three months ended September 30,  2019   2018
Expected volatility 111.4% -112.2%   142%
Risk free interest rate 2.43% - 2.45%   2.63%
Forfeiture rate 20%   20%
Dividend yield 0%   0%
Expected term (years) 5.61    5

 

The remaining amount of unrecognized stock-based compensation expense at September 30, 2019 relating to outstanding stock options, is approximately $1,163,000, which is expected to be recognized over the weighted-average period of 1.71 years.